Jmjd1c was identified as a co-activator of the tumor-inducing fusion gene AML1-ETO and shown to be recruited by AML1-ETO to target gene promoters where it lowers the levels of the repressive mark H3K9me249. Here, RUNX1T1 is linked to neoplasm.